Skip to content
Unrated Medical device recall · FDA · Published March 1, 2021

Cellex qSARS-Cov-2 Antigen Test Recall: No Emergency Use Authorization

Cellex recalls 25-test antigen rapid tests due to lack of emergency use authorization. All units are affected. No remedy provided in official notice.

🇺🇸 FDA recall #Z-2452-2021Medical deviceCellex ›
Take action

Contact the company

Recalling firmCellex507 Airport Blvd Ste 107 · Morrisville, NC 27560-8200
✎ GovInfoNow plain-language explainer

Cellex is recalling all 25-test antigen rapid tests because they were submitted for emergency use authorization but the authorization was denied. This means the tests are not approved for use and could be unsafe. Read more at govinfonow.com/recall/63178-cellex-qsars-cov-2-antigen-test-recall-no-emergency-use.

Source Summary by GovInfoNow · govinfonow.com/recall/63178-cellex-qsars-cov-2-antigen-test-recall-no-emergency-use · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2452-2021

Cite this page

“Cellex qSARS-Cov-2 Antigen Test Recall: No Emergency Use Authorization.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63178-cellex-qsars-cov-2-antigen-test-recall-no-emergency-use. Based on FDA recall #Z-2452-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2452-2021%22&limit=1).

The FDA announced on March 1, 2021, that Cellex voluntarily recalled approximately 44,821 Cellex qSARS-Cov-2 Antigen Rapid Test kits because they lacked an emergency use authorization. The agency stated the kits were distributed nationwide in California, Florida, Texas, and Wisconsin.

How to tell if you have it

  • Brand: Cellex
  • Product: Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box
  • Submission ID: EUA202955
  • Quantity: Approximately 44,821 kits
  • Distribution: US Nationwide in CA, FL, TX, and WI

The hazard

According to the FDA, the hazard is that the Cellex qSARS-Cov-2 Antigen Rapid Test kit does not have an emergency use authorization (EUA). The recall covers all lot numbers of the product submitted as EUA202955.

Context

GovInfoNow's records show other recent recalls of similar diagnostic products include a GET TESTED INTERNATIONAL AB Epstein-Barr Virus Test recalled on November 3, 2025, due to unapproved distribution and a QUCARE Total Cholesterol Test recall on April 2, 2026, for missing FDA clearance. Additional recent actions involve a GET TESTED HPV Antigen Test distributed without premarket approval on November 3, 2025.

How to tell if you have this one

Check for the product name 'Cellex qSARS-Cov-2 Antigen Rapid Test' with 25 tests per box. All lot numbers are affected, so all units are recalled.

  • Brand
    Cellex
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the product name and quantity (25 tests per box) to confirm if it matches the recalled item.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 4 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: named in the noticeWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “US Nationwide distribution in the states of CA, FL, TX, and WI.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: California, Florida, Texas, Wisconsin.

Recall timeline

FDA published this recall 7 months after the firm started it.

1. Firm started the recall: Mar 1, 202112. FDA classified it Class II: Sep 13, 202123. Published in FDA’s Enforcement Report: Sep 22, 202132021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2452-2021 (March 1, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2452-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA